4.5 Article

A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH

期刊

NEUROBIOLOGY OF AGING
卷 33, 期 8, 页码 1807-1815

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2011.02.023

关键词

N-glycan; Transferrin; Glycosylation; Cerebrospinal fluid; Choroid plexus; Dementia; Idiopathic normal pressure hydrocephalus; Alzheimer's disease; Biomarker

资金

  1. New Energy and Industrial Technology Development Organization (NEDO) of Japan
  2. Ministry of Health, Labor and Welfare of Japan [2006-Nanchi-Ippan-017]
  3. Naito Foundation
  4. Ministry of Education, Science, Sports and Culture of Japan [20023023]
  5. Japan Science and Technology Agency
  6. Grants-in-Aid for Scientific Research [20023023] Funding Source: KAKEN

向作者/读者索取更多资源

Idiopathic normal pressure hydrocephalus (iNPH) is an elderly dementia caused by abnormal metabolism in the cerebrospinal fluid (CSF). The tap test is the current basis for confirming iNPH, but it shows very low sensitivity, indicating that many patients who might be cured by a shunt operation will be missed. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we found two transferrin isoforms: one had a unique N-glycan (Tf-1) whereas the other had N-glycan similar to that of serum transferrin (Tf-2). Glycan analyses revealed that Tf-1 had branching (biantennary) asialo- and agalacto-complex type N-glycans (N-acetylglucosamine [GlcNAc]-terminated glycans), which carried bisecting beta 1,4-N-acetylglucosamine and core alpha 1,6-fucose. To examine glycoform whether changes in iNPH, we introduced the Tf-2/Tf-1 ratio as a diagnostic index, which minimized blot-to-blot variations in measurement. The Tf-2/Tf-1 ratios of iNPH patients are significantly higher than those of controls (p = 0.0019) and Alzheimer's patients (p = 0.0010). This suggests that the Tf-2/Tf-1 ratio could distinguish iNPH from Alzheimer's disease, and possibly other dementias. In conclusion, glycoform analysis has diagnostic potential in neurological diseases. (C) 2012 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据